NovaBay Pharmaceuticals, Inc. NBY
1.47 USD 0.00 (+0.00%)
May 22, 2026, 12:37 PM EDT
1.47 Day range 1.47
52-week range unavailable
- YTD
- -94.79%
- 1 year
- -47.32%
Analyst view
Price target (mean) 3.73 +153.4% upside
Now 1.47
- Target (low)
- 0.85
- Target (mean)
- 3.73
- Target (high)
- 6.60
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.24 | -0.24 – -0.24 | -46.55 | +99.5% | 2.50M | -32.9% | 1 |
| Next quarter | -0.305 | -0.37 – -0.24 | -5.34 | +94.3% | 3.00M | +14.0% | 2 |
| Current year | -3.26 | -3.26 – -3.26 | -138.60 | +97.7% | 9.90M | -32.8% | 1 |
| Next year | -0.82 | -0.86 – -0.78 | -3.26 | +74.9% | 12.60M | +27.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Aug 11, 2023 | Ladenburg Thalmann | Maintained | Buy | Buy |